• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C57BL/6小鼠中的呼吸道合胞病毒感染:病毒特异性细胞毒性T细胞清除肺部病毒

Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells.

作者信息

Muñoz J L, McCarthy C A, Clark M E, Hall C B

机构信息

Department of Pediatrics, New York University School of Medicine, New York 10016.

出版信息

J Virol. 1991 Aug;65(8):4494-7. doi: 10.1128/JVI.65.8.4494-4497.1991.

DOI:10.1128/JVI.65.8.4494-4497.1991
PMID:2072460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC248892/
Abstract

We describe respiratory syncytial virus (RSV)-specific cytotoxic T-cell (CTL) lines and clones developed from the spleens of C57BL/6 and BALB/c mice. Line 7 and clones derived from it were H-2Kb restricted, whereas line 12 had both Kb and Db components. Both lines, and all the clones except one, could lyse targets infected with either strain A or strain B RSV. Line 7 or 7-11E1 cells (8 x 10(6) to 10 x 10(6) given intravenously cleared RSV from the lungs of infected mice. There was no morbidity or mortality in any of the infected mice whether or not they received T cells. The C57BL/6 mouse is a useful model system in which to study the role of the CTL response in protective immunity to RSV. CTL lines and clones can mediate clearance of RSV from the lungs of normal mice without producing any associated morbidity.

摘要

我们描述了从C57BL/6和BALB/c小鼠脾脏中培养出的呼吸道合胞病毒(RSV)特异性细胞毒性T细胞(CTL)系及克隆。7号线及其衍生的克隆受H-2Kb限制,而12号线同时具有Kb和Db成分。这两条线以及除一个克隆外的所有克隆,都能裂解感染A株或B株RSV的靶细胞。7号线或7-11E1细胞(静脉注射8×10⁶至10×10⁶个细胞)可清除感染小鼠肺中的RSV。无论是否接受T细胞,任何感染小鼠均未出现发病或死亡情况。C57BL/6小鼠是研究CTL反应在RSV保护性免疫中作用的有用模型系统。CTL系及克隆可介导正常小鼠肺中RSV的清除,且不产生任何相关发病情况。

相似文献

1
Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells.C57BL/6小鼠中的呼吸道合胞病毒感染:病毒特异性细胞毒性T细胞清除肺部病毒
J Virol. 1991 Aug;65(8):4494-7. doi: 10.1128/JVI.65.8.4494-4497.1991.
2
Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.细胞毒性T细胞可清除病毒,但会加剧感染呼吸道合胞病毒小鼠的肺部病变。
J Exp Med. 1988 Sep 1;168(3):1163-8. doi: 10.1084/jem.168.3.1163.
3
The cytolytic activity of pulmonary CD8+ lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice.由表达呼吸道合胞病毒(RSV)M2蛋白的痘苗病毒重组体感染诱导的肺部CD8 +淋巴细胞的细胞溶解活性与小鼠对RSV感染的抵抗力相关。
J Virol. 1993 Feb;67(2):1044-9. doi: 10.1128/JVI.67.2.1044-1049.1993.
4
Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line.小鼠细胞毒性T细胞克隆和人细胞毒性T细胞系对呼吸道合胞病毒融合蛋白的识别
J Gen Virol. 1989 Jan;70 ( Pt 1):79-87. doi: 10.1099/0022-1317-70-1-79.
5
Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus.感染呼吸道合胞病毒的小鼠肺部的细胞毒性淋巴细胞
J Gen Virol. 1985 Dec;66 ( Pt 12):2533-8. doi: 10.1099/0022-1317-66-12-2533.
6
The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.呼吸道合胞病毒的22000千道尔顿蛋白是受感染引发的小鼠中Kd限制细胞毒性T淋巴细胞的主要靶点。
J Virol. 1990 Apr;64(4):1683-9. doi: 10.1128/JVI.64.4.1683-1689.1990.
7
Primary pulmonary murine cytotoxic T lymphocyte specificity in respiratory syncytial virus pneumonia.呼吸道合胞病毒肺炎中肺部原发性鼠细胞毒性T淋巴细胞特异性
Microb Pathog. 1990 Jul;9(1):13-8. doi: 10.1016/0882-4010(90)90036-p.
8
Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.用甲醛灭活的呼吸道合胞病毒(RSV)免疫BALB/c小鼠,然后对其进行RSV攻击所诱导的肺部组织病理学变化,可通过清除CD4+ T细胞而消除。
J Virol. 1992 Dec;66(12):7444-51. doi: 10.1128/JVI.66.12.7444-7451.1992.
9
Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus.由呼吸道合胞病毒融合蛋白的一种H-2K(d)限制性、基序阴性15聚体肽诱导的病毒特异性CTL反应。
J Gen Virol. 2002 Feb;83(Pt 2):429-438. doi: 10.1099/0022-1317-83-2-429.
10
Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.重组呼吸道合胞病毒表达白细胞介素-4与初次感染后炎症加速和细胞毒性T淋巴细胞反应无功能有关,但在野生型病毒攻击后则不然。
J Virol. 2005 Aug;79(15):9515-26. doi: 10.1128/JVI.79.15.9515-9526.2005.

引用本文的文献

1
Immunity Cell Responses to RSV and the Role of Antiviral Inhibitors: A Systematic Review.免疫细胞对呼吸道合胞病毒的反应及抗病毒抑制剂的作用:一项系统综述
Infect Drug Resist. 2022 Dec 14;15:7413-7430. doi: 10.2147/IDR.S387479. eCollection 2022.
2
A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection.一种基于重组 MVA 的 RSV 疫苗可诱导 T 细胞和抗体应答,共同抵抗 RSV 感染。
Front Immunol. 2022 Jun 14;13:841471. doi: 10.3389/fimmu.2022.841471. eCollection 2022.
3
Innate and Adaptive Immunity Imbalance With Severe COVID-19 Pneumonia in Children and Adults.儿童和成人重症新型冠状病毒肺炎的先天性和适应性免疫失衡
Front Pediatr. 2021 Dec 15;9:736013. doi: 10.3389/fped.2021.736013. eCollection 2021.
4
Sex- and age-specific clinical and immunological features of coronavirus disease 2019.新型冠状病毒 2019 年的性别和年龄特异性临床和免疫学特征。
PLoS Pathog. 2021 Mar 26;17(3):e1009420. doi: 10.1371/journal.ppat.1009420. eCollection 2021 Mar.
5
Age cohorts stratified according to age-distributions of COVID-19 morbidity statistics identify uniquely age-dependent CD3CD8 T-cell lymphocytopenia in COVID-19 patients without comorbidities on admission.根据 COVID-19 发病率统计数据的年龄分布对年龄队列进行分层,在入院时无合并症的 COVID-19 患者中识别出独特的与年龄相关的 CD3CD8 T 细胞淋巴细胞减少症。
Aging (Albany NY). 2021 Mar 10;13(6):7713-7722. doi: 10.18632/aging.202691.
6
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.SARS-CoV-2 特异性 T 细胞被快速扩增用于治疗,并针对膜蛋白的保守区域。
Blood. 2020 Dec 17;136(25):2905-2917. doi: 10.1182/blood.2020008488.
7
Viral pneumonia in children.儿童病毒性肺炎
Semin Pediatr Infect Dis. 1998 Jul;9(3):217-233. doi: 10.1016/S1045-1870(98)80035-6. Epub 2006 Jun 3.
8
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.新型冠状病毒肺炎外周血淋巴细胞亚群特征变化。
J Infect Dis. 2020 May 11;221(11):1762-1769. doi: 10.1093/infdis/jiaa150.
9
Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus.当前用于理解呼吸道合胞病毒所致病理的动物模型
Front Microbiol. 2019 May 3;10:873. doi: 10.3389/fmicb.2019.00873. eCollection 2019.
10
Antibody and B cell responses to an investigational adjuvanted RSV vaccine for older adults.针对老年人的一种新型 RSV 疫苗的抗体和 B 细胞反应。
Hum Vaccin Immunother. 2019;15(10):2466-2474. doi: 10.1080/21645515.2019.1589282. Epub 2019 Jun 3.

本文引用的文献

1
The development of Balb/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface.持续感染呼吸道合胞病毒的Balb/c细胞的发育:细胞表面核糖核蛋白的存在。
Proc Soc Exp Biol Med. 1981 May;167(1):83-6. doi: 10.3181/00379727-167-41129.
2
A simplified method for the production of murine T-cell growth factor free of lectin.一种生产无凝集素小鼠T细胞生长因子的简化方法。
J Immunol Methods. 1981;42(2):213-22. doi: 10.1016/0022-1759(81)90151-4.
3
Respiratory syncytial virus infection in mice.小鼠呼吸道合胞病毒感染
Infect Immun. 1984 Feb;43(2):649-55. doi: 10.1128/iai.43.2.649-655.1984.
4
Recognition of Db and Kb gene products by influenza-specific cytotoxic T cells.流感特异性细胞毒性T细胞对Db和Kb基因产物的识别。
Immunogenetics. 1983;17(3):283-94. doi: 10.1007/BF00364412.
5
Development of a serum-free medium which supports the long-term growth of human and nonhuman primate lymphoid cells.一种支持人类和非人类灵长类淋巴样细胞长期生长的无血清培养基的研发。
J Cell Physiol. 1983 May;115(2):191-8. doi: 10.1002/jcp.1041150214.
6
Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.尽管之前接种了抗原性灭活疫苗,但婴儿仍患呼吸道合胞病毒病。
Am J Epidemiol. 1969 Apr;89(4):422-34. doi: 10.1093/oxfordjournals.aje.a120955.
7
Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model.灵长类动物模型呼吸道中呼吸道合胞病毒感染的被动免疫疗法研究。
J Infect Dis. 1985 Nov;152(5):1083-7. doi: 10.1093/infdis/152.5.1083.
8
Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice.重组痘苗病毒载体表达人呼吸道合胞病毒融合蛋白及对接种小鼠的保护作用
J Virol. 1987 Feb;61(2):293-301. doi: 10.1128/JVI.61.2.293-301.1987.
9
Respiratory syncytial viral infection in children with compromised immune function.免疫功能受损儿童的呼吸道合胞病毒感染
N Engl J Med. 1986 Jul 10;315(2):77-81. doi: 10.1056/NEJM198607103150201.
10
Risk of primary infection and reinfection with respiratory syncytial virus.呼吸道合胞病毒原发性感染和再感染的风险。
Am J Dis Child. 1986 Jun;140(6):543-6. doi: 10.1001/archpedi.1986.02140200053026.